UK markets open in 6 hours 5 minutes
NIKKEI 225
37,985.93 -474.15 (-1.23%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.74 -0.07 (-0.08%) GOLD FUTURES
2,330.20 -8.20 (-0.35%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,795.34 -1,762.29 (-3.29%)
Virpax Pharmaceuticals, Inc. (VRPX)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.70M |
| Enterprise value | -5.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.91 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.38 |
| 52-week change 3 | -52.62% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 11.7700 |
| 52-week low 3 | 2.4000 |
| 50-day moving average 3 | 3.7395 |
| 200-day moving average 3 | 5.8373 |
Share statistics
| Avg vol (3-month) 3 | 24.74k |
| Avg vol (10-day) 3 | 7.21k |
| Shares outstanding 5 | 1.17M |
| Implied shares outstanding 6 | 1.17M |
| Float 8 | 1.14M |
| % held by insiders 1 | 25.72% |
| % held by institutions 1 | 3.26% |
| Shares short (28 Mar 2024) 4 | 29.83k |
| Short ratio (28 Mar 2024) 4 | 0.57 |
| Short % of float (28 Mar 2024) 4 | 3.43% |
| Short % of shares outstanding (28 Mar 2024) 4 | 2.55% |
| Shares short (prior month 29 Feb 2024) 4 | 10.85k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 01 Mar 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -55.20% |
| Return on equity (ttm) | -164.09% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -15.19M |
| Diluted EPS (ttm) | -12.9700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9.14M |
| Total cash per share (mrq) | 7.8 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.25 |
| Book value per share (mrq) | 1.65 |
Cash flow statement
| Operating cash flow (ttm) | -9.85M |
| Levered free cash flow (ttm) | -2.75M |
© 2024 Yahoo. All rights reserved.